HCA Healthcare, Inc. (NYSE:HCA) Position Boosted by Evexia Wealth LLC

Evexia Wealth LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,748 shares of the company’s stock after purchasing an additional 601 shares during the period. Evexia Wealth LLC’s holdings in HCA Healthcare were worth $3,139,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HCA. MML Investors Services LLC raised its holdings in HCA Healthcare by 31.7% during the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after purchasing an additional 4,285 shares in the last quarter. Galvin Gaustad & Stein LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at $18,044,000. NRI Wealth Management LC acquired a new position in HCA Healthcare during the fourth quarter worth about $2,896,000. Czech National Bank boosted its position in shares of HCA Healthcare by 4.5% during the 4th quarter. Czech National Bank now owns 39,543 shares of the company’s stock valued at $11,869,000 after purchasing an additional 1,691 shares in the last quarter. Finally, Peak Financial Advisors LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth approximately $1,122,000. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of several research reports. Bank of America dropped their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Royal Bank of Canada dropped their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Barclays cut their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Truist Financial lowered their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Up 0.4 %

HCA Healthcare stock opened at $331.05 on Wednesday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $81.51 billion, a P/E ratio of 15.07, a P/E/G ratio of 1.10 and a beta of 1.48. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The firm’s fifty day simple moving average is $327.29 and its 200-day simple moving average is $337.96.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the business posted $5.90 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a $0.72 dividend. The ex-dividend date of this dividend was Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. HCA Healthcare’s payout ratio is presently 13.11%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.